Liquid chromatographic assay in plasma of one of the members of a new series of anticonvulsants: D,L-3-hydroxy-3-ethyl-3-phenylpropionamide.
A method for the simultaneous determination of HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide), a member of a new homologous series of phenylamide-derivative anticonvulsants, with six other antiepileptic drugs (ethosuximide, primidone, phenobarbital, phenytoin, carbamazepine and clonazepam) in plasma by high-performance liquid chromatography is described. These drugs are extracted from plasma by adding an equal volume of acetonitrile. An aliquot of the extract is then injected on a reversed-phase column with a acetonitrile-methanol-phosphate buffer mobile phase. The total time required for the whole analytical process, including the plasma pretreatment and chromatography, is approximately 30 min. The assay method is simple, rapid and reproducible, and therefore considered suitable for routine use in clinical investigations monitoring HEPP simultaneously with common antiepileptic drugs.
Martínez de Muñoz
D
D
Department of Physiology, Biophysics and Neurosciences, Centro de Investigación y de Estudios Avanzados del IPN, Mexico, D.F., Mexico.
Arenas
R
R
Chávez González
O
O
D000097:Acetonitriles; D000927:Anticonvulsants / Q000097:blood*; D002853:Chromatography, Liquid / Q000379:methods*; D006801:Humans; D010666:Phenylpropionates / Q000097:blood*
D000097:Acetonitriles; D000927:Anticonvulsants; D010666:Phenylpropionates; C067697:beta-hydroxy-beta-ethyl-phenylpropionamide; C032159:acetonitrile